Dr Thangaraj's main research interests lie within the area of ethical and socially responsible management of intellectual property (IP).
His work places particular emphasis on managing IP to help make available health technologies and products at the lowest possible cost, to poorer populations in low to middle income countries.
A corresponding aspect of his work also the “socially responsible licensing” of health technologies protected by IP (principally, patents) in a manner that balances commercial imperatives and profit with social imperatives such as affordability and dissemination of knowledge.
Dr Thangaraj is available for consultancies on patent landscape analyses on health technologies, teaching on IP basics and conduction of patent searches, and capacity building in IP matters for developing countries.
Institutions for which he has provided services include MRC Innovations London and the Institute for Prospective Technological Studies (IPTS), Seville, Spain.
Dr Thangaraj is the scientific and administrative coordinator for a project entitled “Access to Pharmaceuticals” funded by the European Union under its Framework 7 (Health) Programme. In addition, he leads a focus group on IP management for the European COST Action on Molecular Farming that co-ordinates research and policy activities in 28 European countries.
He is also a part-qualified patent attorney for the profession in the UK. He serves on the Advisory Board for an initiative by the Institute of Physics which develops curricula for the teaching of Physics in developing countries. In addition, he participates in external teaching workshops on IP management.
Prior to engaging in IP research, he has had several years of postdoctoral research experience relating to Mycobacterial pathogens and diseases.
Winner of the GlaxoSmithKline (GSK) prize for highest score in Patent Law examinations (Queen Mary University London).
Thangaraj H, van Dolleweerd CJ, McGowan EG, Ma K-C. Dynamics of global disclosure through patent and journal publications for biopharmaceutical products. Nature Biotechnology 2009; 27(7):614-8.
Busang R, Boisjoly-Letourneau K, Mulder M, Fourie B, Schiermeier A, Thangaraj H. Socially responsible licensing of health technologies: Policy and practice in South Africa. Les Nouvelles (Journal of the Licensing Executive Society International) June 2011
Drake PM, Thangaraj H. Molecular farming, patents and access to medicines. Expert Review of Vaccines. 2010; 9(8):811-9.
Thangaraj H, Reljic R. Social leverage of intellectual property: Road to the development of better therapy for tuberculosis. Recent Patents on Anti-Infective Drug Discovery. 2009; 4(2):114-22.
Thangaraj H, Potter R and Krattiger A. How and where to search for IP information on the World Wide Web. 2007 Book chapter in: Intellectual Property Management in Health and Agricultural Innovation: A Handbook of Best Practices (Vol. II: ISBN: 978-1-4243-2027-1)
Thangaraj H, Kanesarajah V. (2008) The Cocoa Genome – Breaking Intellectual Property Barriers. Thomson Reuters KnowledgeLink Monthly. June 2008.
Professor Daniel Kraus, Faculty of Health Law, University of Neuchatel
Professor Carlos Morel, Oswaldo Cruz Foundation, Brazil
Professor Tony Bunn, South African Medical Research Council
Professor Richard Mahoney, International Vaccine Institute, South Korea
European Union (FP7 Health)